ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2884

Correlation between Salivary Gland Ultrasonography, Minor Salivary Gland Histhopatology and Sialometry: Towards a Composite Assessment of Salivary Gland Involvement in Primary Sjögren’s Syndrome

Chiara Baldini1, Nicoletta Luciano1, Francesco Ferro1, Antonella Cecchettini2, Valentina Donati3, Marta Mosca1 and Stefano Bombardieri1, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2IFC, CNR, Pisa, Italy, 3Pathology Unit, University of Pisa, Pisa, Italy

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Salivary gland, salivary hypofunction and ultrasonography, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: 5T110 ACR Abstract: Sjögren's Syndrome–Basic & Clinical Science (2880–2885)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:: Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease that specifically involves salivary glands. Several complementary tools including salivary gland ultrasonography (SGUS), histology and saliva collection have been proposed to estimate glandular inflammation and dysfunction. Few studies have explored the association between SGUS, salivary gland histology and saliva production. Moreover, it has to be elucidated whether an integrated composite evaluation of salivary gland involvement, based on the combination of these different tools, may improve patients’ stratification and management. Aims of this study were: 1) to analyze the correlation between SGUS, saliva production and gland histology, and 2) to assess the prevalence of different subsets of glandular involvement in pSS defined on the basis of the combination of SGUS, histology and sialometry.

Methods: Newly diagnosed pSS patients were consecutively enrolled. Subjects underwent a complete rheumatologic evaluation, SGUS, minor salivary gland biopsy and sialometry (USFR). SGUS was performed by the same operator who graded the echostructure of each gland on a 5-point scale (0–4), defining as pathological a SGUS score ≥2 . Histology evaluation included the assessment of the focus score (FS) and the reporting of the number of germinal centre (GC)-like structures.

Results: We included 90 newly diagnosed pSS patients. Out of them: 51 presented abnormal findings at SGUS and 39 had a normal SGUS. SGUS score correlated better with FS (r=0.642, p=0.001) and GCs (r=0.492, p=0.001) than with USFR (r=-0.361, p=0.003). When SGUS findings were combined with histology and USFR we distinguished four major patterns of salivary involvement. The most common subset was represented by patients (26/90 (29%)) with abnormal SGUS, preserved USFR and a high FS. In addition, 21/90 (23%) pSS patients presented abnormal SGUS findings, reduced USFR and a high FS; 17/90 (19%) patients had normal SGUS, preserved USFR and a low FS, and 17/90 (19%) had normal SGUS, preserved USFR and a high FS. Nine patients presented characteristics intermediate between the mentioned subsets. Patients included in the first two groups presented a higher frequency of anti-Ro/SSA, Rheumatoid factor, hypergammaglobulinemia and salivary gland swelling. Patients with lower USFR presented a reduced size in their submandibular glands at SGUS examination.

Conclusion: This study suggest that an integrated evaluation of salivary gland involvement may allow to better define the relationship between tissue inflammation/damage and functional dysfunction. This composite approach may be useful in pSS phenotyping as a prerequisite towards personalized interventions.


Disclosure: C. Baldini, None; N. Luciano, None; F. Ferro, None; A. Cecchettini, None; V. Donati, None; M. Mosca, None; S. Bombardieri, None.

To cite this abstract in AMA style:

Baldini C, Luciano N, Ferro F, Cecchettini A, Donati V, Mosca M, Bombardieri S. Correlation between Salivary Gland Ultrasonography, Minor Salivary Gland Histhopatology and Sialometry: Towards a Composite Assessment of Salivary Gland Involvement in Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/correlation-between-salivary-gland-ultrasonography-minor-salivary-gland-histhopatology-and-sialometry-towards-a-composite-assessment-of-salivary-gland-involvement-in-primary-sjogrens-syndro/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-salivary-gland-ultrasonography-minor-salivary-gland-histhopatology-and-sialometry-towards-a-composite-assessment-of-salivary-gland-involvement-in-primary-sjogrens-syndro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology